about
Amyloid beta (A4) precursor proteinCiliary neurotrophic factorInterleukin 1 betaFormyl peptide receptor 2Adenosine A2a receptorInterferon gammaFormyl peptide receptor 2Interferon gammaPresenilin 1Adenosine A2a receptorInterferon gamma receptor 1AngiotensinogenEpidermal growth factor receptorSmoothened, frizzled class receptorInterferon gammaCiliary neurotrophic factorBeta-secretase 2Presenilin 1Adenosine A2a receptorFormyl peptide receptor 2Interleukin 1 betaEpidermal growth factor receptorCiliary neurotrophic factorSmoothened, frizzled class receptorInterleukin 1 betaMicrotubule associated protein tauAmyloid beta precursor proteinEpidermal growth factor receptorPresenilin 1Beta-secretase 2Interferon gammaCiliary neurotrophic factorInterferon gamma receptor 1Interferon gamma receptor 1
P682
Immune regulation and CNS autoimmune disease.Cytokines: powerful regulators of glial cell activation.Interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells.Glial-derived proteins activate cultured astrocytes and enhance beta amyloid-induced glial activation.Mechanisms of P2X7 receptor-mediated ERK1/2 phosphorylation in human astrocytoma cells.Interaction between apoptotic cells and reactive brain cells in the central nervous system of rats with autoimmune encephalomyelitis.
P921
Q14865884-96EBADF7-F9AA-427B-A1D5-32BC742922ACQ14906195-D81DC559-56B0-40B8-91BC-5AC5D739D521Q14916414-0F0768EB-639E-4BE8-851A-FD1A936DF05DQ21107443-BBAAB84D-A07F-44E6-A9A3-E7DEADD37B56Q21116162-99280D95-DF38-4737-9ACC-A7296ED6DEA8Q21173277-E33A84A6-340C-4D0A-8818-6AE0D8D4FA28Q21421202-3236F423-917A-4741-9CCF-57008F96D435Q21494550-CEE5EDFC-8EF1-428D-94B2-275C34B5758FQ21496912-93CCCACC-BBB0-45EF-AC25-77AE59A1176EQ21498708-6E905261-9E29-4BAD-A729-DF7B8D1F2D8DQ21979973-0C9E5E76-C2F5-4F5A-A35A-5D48F454855CQ21981190-A3774043-BB16-4BEF-A401-CD0DAE8FBDDCQ21981692-0D8031CF-CE4F-42FA-817C-BFE8562B15DCQ21986823-E07168E3-D537-42B2-ABCD-7590105ED430Q28556382-B27FA345-58FF-4515-8B86-A92A6CF0462DQ28558655-75C91EC2-520A-4137-A919-A1EE3AB032FBQ28558790-1C67FF90-637C-4107-A2DD-784146FA1B55Q28560529-F321DD9B-5D6E-42E8-9553-2F50C654BE1AQ28560964-F4BDA0C7-A413-4673-B004-AB542FF1C6F9Q29522009-10F2AD96-3A73-49CF-AEFA-A09AA263682FQ29524682-D4979C6C-8258-46A3-A91E-54B2A9F04724Q29525970-1F5F067A-1BDA-45E6-B5C2-231647004243Q29834960-F246A4A3-91C3-459A-A36E-2A7BDB18F633Q3271551-93003F19-7A7D-4040-9165-3B1C99B79BA5Q411529-A1181681-0E20-4B45-A67B-0A71D06C37D4Q419507-DA46D2E0-7CF6-4735-BE83-6AE4F7BD368BQ423510-C07841BB-7850-4B16-B088-2E0C4A9F7251Q424401-1E533259-3B4B-4715-BC30-2C7B51F709A2Q4377404-1427060A-2AFF-4ECA-838E-E942110E3509Q4897229-464CFF61-5448-4682-8E0C-4F98AA2D72F6Q50854787-921A6CE3-E5E4-4CAA-B08D-907A2DD91949Q5119950-B0C705A4-A583-4D6C-B683-78EF1544E058Q55203659-DEC80780-1C31-47AF-A458-3C1DD5E2D010Q6046452-BAE53C53-D61E-4301-8EDF-C91C7B2C7907
P682
description
A change in morphology and beh ...... lar ligand, or soluble factor.
@en
biologisch proces
@nl
name
astrocyt aktivering
@da
astrocyte activation
@en
type
label
astrocyt aktivering
@da
astrocyte activation
@en
altLabel
GO:0048143
@en
prefLabel
astrocyt aktivering
@da
astrocyte activation
@en
P2888
P686
GO:0048143